Given that our in silico analysis demonstrated that SPRY4 promoter hypomethylation inversely correlated with increased mRNA expression in large CRC datasets prompted us to confirm differential methylation within the distal promoter regions of SPRY4 in CRC patient samples. The gene discussed is SPRY4; the disease is colorectal carcinoma.